1.A Comparison of Smoking Control Strategies in Korea and the United States.
Chung Yul LEE ; Ok Kyung HAM ; Yoon Mi HONG
Journal of Korean Academy of Nursing 2004;34(8):1379-1387
The purpose of this study was to compare smoking control strategies between Korea and the United States. Korea and other developing countries may learn from the experience of the United States in dealing with the growing epidemic of cigarettes. In particular, smoking control objectives, structures, laws and regulations, funds, programs and activities, research, and surveillance systems were compared. The comparison was conducted at the federal, states/provincial, and county levels of the two countries. The data were collected through various governmental websites, contact with people directly, and a literature review. Based on the comparison, seven recommendations for smoking control strategies were made primarily for Korea.
Cross-Cultural Comparison
;
Federal Government
;
Financing, Government/organization & administration
;
Government Programs/*organization & administration
;
Government Regulation
;
Health Education/organization & administration
;
Health Policy/legislation & jurisprudence
;
Health Priorities/organization & administration
;
Health Promotion/*organization & administration
;
Humans
;
Korea/epidemiology
;
Local Government
;
Population Surveillance
;
*Public Health Practice/economics/legislation & jurisprudence
;
Research Support as Topic/organization & administration
;
Smoking/epidemiology/*legislation & jurisprudence/*prevention & control
;
Smoking Cessation/legislation & jurisprudence/methods
;
State Government
;
United States/epidemiology
3.Is cost-effective healthcare compatible with publicly financed academic medical centres?
Whay Kuang CHIA ; Han Chong TOH
Annals of the Academy of Medicine, Singapore 2013;42(1):42-48
Probably more than any country, Singapore has made significant investment into the biomedical enterprise as a proportion of its economy and size. This focus recently witnessed a shift towards a greater emphasis on translational and clinical development. Key to the realisation of this strategy will be Academic Medical Centres (AMCs), as a principal tool to developing and applying useful products for the market and further improving health outcomes. Here, we explore the principal value proposition of the AMC to Singapore society and its healthcare system. We question if the values inherent within academic medicine--that of inquiry, innovation, pedagogy and clinical exceptionalism--can be compatible with the seemingly paradoxical mandate of providing cost-effective or rationed healthcare.
Academic Medical Centers
;
economics
;
organization & administration
;
Cost-Benefit Analysis
;
Financing, Government
;
Health Care Costs
;
Health Care Rationing
;
Quality of Health Care
;
Singapore
4.2015 National Health Accounts and Current Health Expenditures in Korea.
Hyoung Sun JEONG ; Jeong Woo SHIN
Health Policy and Management 2017;27(3):199-210
BACKGROUND: This paper aims to demonstrate current health expenditure (CHE) and National Health Accounts of the years 2015 constructed according to the SHA2011, which is a new manual of System of Health Accounts (SHA) that was published jointly by the Organization for Economic Cooperation and Development (OECD), Eurostat, and World Health Organization in 2011. Comparison is made with international trends by collecting and analysing health accounts of OECD member countries. Particularly, financing public- private mix is parsed in depth using SHA data of both HF as financing schemes as well as FS (financing source) as their revenue types. METHODS: Data sources such as Health Insurance Review and Assessment Service's publications of both motor insurance and drugs are newly used to construct the 2015 National Health Accounts. In the case of private financing, an estimation of total expenditures for revenues by provider groups is made from the Economic Census data; and the household income and expenditure survey, Korean healthcare panel study, etc. are used to allocate those totals into functional classifications. RESULTS: CHE was 115.2 trillion won in 2015, which accounts for 7.4 percent of Korea's gross domestic product. It was a big increase of 9.3 trillion won, 8.8 percent, from the previous year. Government and compulsory schemes's share (or public share) of 56.4% of the CHE in 2015 was much lower than the OECD average of 72.6%. ‘Transfers from government domestic revenue’ share of total revenue of HF was 17.8% in Korea, lower than the other contribution-based countries. When it comes to ‘compulsory contributory health financing schemes,’‘Transfers from government domestic revenue’ share of 14.9% was again much lower compared to Japan (44.7%) and Belgium (34.8%) as contribution-based countries. CONCLUSION: Considering relatively lower public financing share in the inpatient care as well as overall low public financing share of total CHE, priorities in health insurance coverage need to be repositioned among inpatient care, outpatient care and drugs.
Ambulatory Care
;
Belgium
;
Censuses
;
Classification
;
Delivery of Health Care
;
Family Characteristics
;
Financing, Government
;
Gross Domestic Product
;
Health Expenditures*
;
Healthcare Financing
;
Humans
;
Information Storage and Retrieval
;
Inpatients
;
Insurance
;
Insurance, Health
;
Japan
;
Korea*
;
Organisation for Economic Co-Operation and Development
;
World Health Organization
5.2015 National Health Accounts and Current Health Expenditures in Korea.
Hyoung Sun JEONG ; Jeong Woo SHIN
Health Policy and Management 2017;27(3):199-210
BACKGROUND: This paper aims to demonstrate current health expenditure (CHE) and National Health Accounts of the years 2015 constructed according to the SHA2011, which is a new manual of System of Health Accounts (SHA) that was published jointly by the Organization for Economic Cooperation and Development (OECD), Eurostat, and World Health Organization in 2011. Comparison is made with international trends by collecting and analysing health accounts of OECD member countries. Particularly, financing public- private mix is parsed in depth using SHA data of both HF as financing schemes as well as FS (financing source) as their revenue types. METHODS: Data sources such as Health Insurance Review and Assessment Service's publications of both motor insurance and drugs are newly used to construct the 2015 National Health Accounts. In the case of private financing, an estimation of total expenditures for revenues by provider groups is made from the Economic Census data; and the household income and expenditure survey, Korean healthcare panel study, etc. are used to allocate those totals into functional classifications. RESULTS: CHE was 115.2 trillion won in 2015, which accounts for 7.4 percent of Korea's gross domestic product. It was a big increase of 9.3 trillion won, 8.8 percent, from the previous year. Government and compulsory schemes's share (or public share) of 56.4% of the CHE in 2015 was much lower than the OECD average of 72.6%. ‘Transfers from government domestic revenue’ share of total revenue of HF was 17.8% in Korea, lower than the other contribution-based countries. When it comes to ‘compulsory contributory health financing schemes,’‘Transfers from government domestic revenue’ share of 14.9% was again much lower compared to Japan (44.7%) and Belgium (34.8%) as contribution-based countries. CONCLUSION: Considering relatively lower public financing share in the inpatient care as well as overall low public financing share of total CHE, priorities in health insurance coverage need to be repositioned among inpatient care, outpatient care and drugs.
Ambulatory Care
;
Belgium
;
Censuses
;
Classification
;
Delivery of Health Care
;
Family Characteristics
;
Financing, Government
;
Gross Domestic Product
;
Health Expenditures*
;
Healthcare Financing
;
Humans
;
Information Storage and Retrieval
;
Inpatients
;
Insurance
;
Insurance, Health
;
Japan
;
Korea*
;
Organisation for Economic Co-Operation and Development
;
World Health Organization
6.1970-2014 Current Health Expenditures and National Health Accounts in Korea: Application of SHA2011.
Hyoung Sun JEONG ; Jeong Woo SHIN
Health Policy and Management 2016;26(2):95-106
A new manual of System of Health Accounts (SHA) 2011, was published jointly by the Organization for Economic Cooperation and Development (OECD), Eurostat, and World Health Organization in 2011. This offers more complete coverage than the previous version, SHA 1.0, within the functional classification in areas such as prevention and a precise approach for tracking financing in the health care sector using the new classification of financing schemes. This paper aims to demonstrate current health expenditure (CHE) and National Health Accounts of the years 1970-2014 constructed according to the SHA2011. Data sources for public financing include budget and settlement documents of the government, various statistics from the National Health Insurance, and others. In the case of private financing, an estimation of total revenue by provider groups is made from the Economic Census data and the household income and expenditure survey, Korean healthcare panel study, etc. are used to allocate those totals into functional classifications. CHE was 105 trillion won in 2014, which accounts for 7.1% of Korea's gross domestic product. It was a big increase of 7.7 trillion won, 7.9%, from the previous year. Public share (government and compulsory schemes) accounting for 56.5% of the CHE in 2014 was still much lower than the OECD average of about 73%. With these estimates, it is possible to compare health expenditures of Korea and other countries better. Awareness and appreciation of the need and gains from applying SHA2011 for the health expenditure classification are expected to increase as OECD health expenditure figures get more frequently quoted among health policy makers.
Budgets
;
Censuses
;
Classification
;
Delivery of Health Care
;
Family Characteristics
;
Financing, Government
;
Gross Domestic Product
;
Health Care Sector
;
Health Expenditures*
;
Health Policy
;
Information Storage and Retrieval
;
Korea*
;
National Health Programs
;
Organisation for Economic Co-Operation and Development
;
World Health Organization